Medical progress, in service of a better life.
The future care we imagine combines precise science with patient listening: not only test results, but where you hope to go, who matters to you and what makes daily life meaningful.
Care can feel warmer, easier to understand and more respectful of personal choice. This is CELUNIOUS’s aspiration for the future.
How does cell research reach clinical care?
Progress in regenerative medicine depends on repeated observation, validation and follow-up. Cell source, preparation, quality and clinical findings need clear records, and promising findings need further investigation.
Follow the timeline of scientific progress.
The following draws on official award, university, regulatory and developer sources. It explains scientific progress; it does not imply an award, endorsement or availability of these treatments at CELUNIOUS, GLORIOUS or its partner clinic.
Award history ·
A Nobel Prize for cell reprogramming
Shinya Yamanaka and John B. Gurdon shared the 2012 Nobel Prize in Physiology or Medicine for discovering that mature cells can be reprogrammed to pluripotency.
Clinical research milestone ·
iPS-derived cardiomyocyte sheets in clinical research
The University of Osaka describes the first human transplantation in its doctor-initiated trial in January 2020, studying the sheets’ safety and efficacy.
Regulatory milestone ·
Conditional, time-limited approval for RiHEART
Japan approved the iPS-derived cardiomyocyte sheet RiHEART. PMDA specifies severe heart failure from ischemic cardiomyopathy inadequately responsive to standard care and notes that clinical evidence remains limited.
Coverage update ·
Coverage of a second transplantation
Developer CUORiPS updated coverage of a press briefing on a second transplantation, linking to NHK and other reports. This is the update date; a case report does not establish long-term outcomes.
Who may wish to learn more or seek assessment?
Age and appearance do not determine suitability for cell treatment. Clarify the purpose of an inquiry, then have a doctor assess health, medical history, test results, current care and risks.
- Health management and checkups | Adults seeking health assessment, checkups or continuing follow-up can inquire about care coordination. This does not mean that cell treatment is needed.
- Autologous adipose-derived stem cells | Assessment may be relevant to patients with a condition corresponding to a plan’s treatment purpose who meet that plan’s screening requirements, as determined by SunField doctors.
- iPS-derived cardiomyocyte sheets | Intended for severe heart failure caused by ischemic cardiomyopathy inadequately responsive to standard treatment, subject to product criteria and qualified specialist assessment.
- Conditioned medium | Assessment depends on the specific preparation, source, use and individual. Fatigue, a wish to look younger or age alone does not determine suitability.
How do iPS cells, stem cells and conditioned medium differ?
iPS-derived cardiomyocyte sheets, autologous adipose mesenchymal stem cells and conditioned medium differ in source, preparation, use and evidence. News about heart-cell sheets does not directly establish effects of other cell procedures, conditioned medium or supplements.
This website has not confirmed RiHEART or iPS-derived cardiomyocyte-sheet transplantation at its partner clinic. This material is science information; treatment requires assessment at an appropriately qualified specialist institution.
A life with vitality and room to breathe.
A morning run by the water with friends, a curious journey to an unfamiliar city, time for people and pursuits you love. We hope scientific progress can ultimately respond to these vivid, everyday wishes.
The youthful scene is a future-living vision, not a result of a product or treatment making people younger. Regenerative medicine needs rigorous research and respectful care for each individual.
Sources and reading notes
Understand your options before deciding what comes next.
This page presents future visions and science information. iPS-derived cardiomyocyte sheets are not a confirmed bookable partner-clinic service on this website. Ask Emmy about overseas checkups, interpreting and care coordination; medical institutions confirm acceptance and treatment.
Ask about information and care coordinationContact Emmy · emmy@gloriousgrp.com
For an initial inquiry, tell us the topic and your preferred language. Confirm how records should be submitted before providing necessary information. Please do not send complete medical records or identity documents by ordinary email.